Osteoporotic fractures: an unrecognized adverse event of immune checkpoint inhibitors?
The widespread use of immune checkpoint inhibitors (ICIs) in clinical practice has broadened our understanding of their immune-related adverse events (irAEs). IrAEs, including musculoskeletal adverse events, remain a significant concern. While ICI-ass…